March 21 (Reuters) - Fennec Pharmaceuticals Inc:
* FENNEC PHARMACEUTICALS RECEIVES FAST TRACK DESIGNATION BY FDA FOR PEDMARK
* FENNEC PHARMACEUTICALS- U.S. FDA GRANTED PEDMARK FAST TRACK DESIGNATION FOR PREVENTION OF CISPLATIN-RELATED OTOTOXICITY IN PEDIATRIC PATIENTS WITH SR-HB Source text for Eikon: Further company coverage: